Adobe Duolingo: Which Technology Stock Is Best in 2026
Adobe and Duolingo sit at opposite ends of the tech stock spectrum: one is a cash-generating powerhouse, the other a ...
Investing
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
17,689 articlesPrediction: Monero Will Overtake Cardano by 2028 in Crypto
Could Monero surpass Cardano by 2028? This article lays out the pathways, risks, and strategies for investors trackin...
Prediction: Won't Recognize Enbridge in 15 Years: What Changes the Story
As energy markets shift, a bold forecast asks whether Enbridge will look the same in 15 years. This analysis breaks d...
Intel Drop, Nvidia Slips in Korea-Led Chip Selloff
A Korea-led chip selloff pulled AMD and Intel lower while Nvidia slipped, prompting analysts to frame the move as hea...
Three Defensive Anchors for Investors with $1.5 Million
As markets adjust to higher-for-longer rates, three Dividend Kings stand out as defensive anchors for a $1.5 million ...
Over Analysts Rate Buy: AMD's Bull Case Gains Momentum
More than 40 analysts now rate AMD a Buy as AI-driven data center demand fuels growth. Here’s why the stock could pus...
Forget Super Micro Computer: Buy This AI Hardware Stock Now
As AI server demand remains robust, one legacy tech giant stands out as a buy-after-pullback play. This piece weighs ...
Prediction: Chevron Could Drop as Oil Slips in Markets
Oil weakness adds pressure on Chevron as analysts weigh earnings visibility and cash returns. A rising risk of a drop...
Wall Street Fixated Wrong: A Trillion-Dollar Cash Engine Is a Buy
A tech giant lanes three high-margin engines—cloud, ads, and subscriptions—on a profitable retail base, challenging m...
MAGY Magnificent Seven Income ETF Expands Monday Payouts
MAGY, the MAGY Magnificent Seven Covered Call ETF, now offers a Monday-morning income payout. The fund uses an active...
Social Security Retirees Looking at a Big COLA Rise in 2027
Inflation fuels expectations for a sizable 2027 COLA. If the projection holds, social security retirees looking ahead...
Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...